Article

Rajeev, SP, Roberts, CA, Brown, E, Sprung, VS, Harrold, JA, Halford, JCG, Stancak, A, Boyland, EJ, Kemp, GJ, Perry, J, Howarth, E, Jackson, R, Wiemken, A, Schwab, R, Cuthbertson, DJ and Wilding, JPH (2023) No evidence of compensatory changes in energy balance, despite reductions in body weight and liver fat, during dapagliflozin treatment in type 2 diabetes mellitus: A randomised, double-blind, placebo-controlled, cross-over trial (ENERGIZE). Diabetes, Obesity and Metabolism. ISSN 1462-8902

Brown, E, Wilton, MM, Sprung, VS, Harrold, JA, Halford, JCG, Stancak, A, Burgess, M, Howarth, E, Umpleby, AM, Kemp, GJ, Wilding, JPH and Cuthbertson, DJ (2021) A randomised, controlled, double blind study to assess mechanistic effects of combination therapy of dapagliflozin with exenatide QW versus dapagliflozin alone in obese patients with type 2 diabetes mellitus (RESILIENT): study protocol. BMJ Open, 11 (7). ISSN 2044-6055

Davies, KAB, Norman, JA, Thompson, A, Mitchell, KL, Harrold, JA, Halford, JCG, Wilding, JPH, Kemp, GJ, Cuthbertson, DJ and Sprung, VS (2021) Short-Term Physical Inactivity Induces Endothelial Dysfunction. Frontiers in Physiology, 12. ISSN 1664-042X

Sprung, VS, Bowden Davies, KA, Norman, JA, Thompson, A, Mitchell, KL, Wilding, JPH, Kemp, GJ and Cuthbertson, DJ (2020) Metabolic syndrome is associated with reduced flow mediated dilation independent of obesity status. European Journal of Endocrinology, 183 (2). pp. 211-220. ISSN 0804-4643

Sprung, VS, Kemp, GJ, Wilding, JP, Adams, V, Murphy, K, Burgess, M, Emegbo, S, Thomas, M, Needham, AJ, Weimken, A, Schwab, RJ, Manuel, A, Craig, SE and Cuthbertson, DJ (2020) Randomised, cOntrolled Multicentre trial of 26 weeks subcutaneous liraglutide (a glucagon-like peptide-1 receptor Agonist), with or without contiNuous positive airway pressure (CPAP), in patients with type 2 diabetes mellitus (T2DM) and obstructive sleep apnoEa (OSA) (ROMANCE): study protocol assessing the effects of weight loss on the apnea-hypnoea index (AHI). BMJ Open, 10 (7). ISSN 2044-6055

Davies, KAB, Pickles, S, Sprung, VS, Kemp, GJ, Alam, U, Moore, DR, Tahrani, AA and Cuthbertson, DJ (2019) Reduced physical activity in young and older adults: metabolic and musculoskeletal implications. Therapeutic Advances in Endocrinology and Metabolism, 10. ISSN 2042-0188

Bowden Davies, KA, Sprung, VS, Norman, JA, Thompson, A, Mitchell, KL, Harrold, JA, Finlayson, G, Gibbons, C, Wilding, JPH, Kemp, GJ, Hamer, M and Cuthbertson, DJ (2019) Physical Activity and Sedentary Time: Association with Metabolic Health and Liver Fat. Medicine & Science in Sports & Exercise. ISSN 0195-9131

Bowden Davies, KA, Sprung, VS, Norman, JA, Thompson, A, Mitchell, KL, Halford, JCG, Harrold, JA, Wilding, JPH, Kemp, GJ and Cuthbertson, DJ (2018) Short-term decreased physical activity with increased sedentary behaviour causes metabolic derangements and altered body composition: effects in individuals with and without a first-degree relative with type 2 diabetes. Diabetologia, 61 (6). pp. 1282-1294. ISSN 0012-186X

Rajeev, SP, Sprung, VS, Roberts, C, Harrold, JA, Halford, JCG, Stancak, A, Boyland, EJ, Kemp, GJ, Cuthbertson, DJ and Wilding, JPH (2017) Compensatory changes in energy balance during dapagliflozin treatment in type 2 diabetes mellitus: a randomised double-blind, placebo-controlled, cross-over trial (ENERGIZE)-study protocol. BMJ, 7 (1). ISSN 1756-1833

Pugh, CJ, Sprung, VS, Jones, H, Richardson, P, Shojaee-Moradie, F, Umpleby, AM, Green, DJ, Cable, NT, Trenell, MI, Kemp, GJ and Cuthbertson, DJ (2016) Exercise-induced improvements in liver fat and endothelial function are not sustained 12 months following cessation of exercise supervision in non-alcoholic fatty liver disease (NAFLD). International Journal of Obesity. ISSN 0307-0565

Cuthbertson, DJ, Shojaee-Moradie, F, Sprung, VS, Jones, H, Pugh, CJ, Richardson, P, Kemp, GJ, Barrett, M, Jackson, NC, Thomas, EL, Bell, JD and Umpleby, AM (2015) Dissociation between exercise-induced reduction in liver fat and changes in hepatic and peripheral glucose homoeostasis in obese patients with non-alcoholic fatty liver disease. Clinical Science, 130 (2). pp. 93-104. ISSN 1470-8736

Dobson, R, Burgess, MI, Sprung, VS, Irwin, A, Hamer, M, Jones, J, Daousi, C, Adams, V, Kemp, GJ, Shojaee-Moradie, F, Umpleby, M and Cuthbertson, DJ (2015) Metabolically healthy and unhealthy obesity: differential effects on myocardial function according to metabolic syndrome, rather than obesity. International Journal of Obesity, 40 (1). pp. 153-161. ISSN 0307-0565

Cuthbertson, DJ, Irwin, A, Sprung, VS, Jones, H, Pugh, CJA, Daousi, C, Adams, VL, Bimson, WE, Shojaee Moradie, F, Richardson, P, Umpleby, AM, Wilding, JP and Kemp, GJ (2014) Ectopic lipid storage in non-alcoholic fatty liver disease is not mediated by impaired mitochondrial oxidative capacity in skeletal muscle. CLINICAL SCIENCE, 127 (11-12). pp. 655-663. ISSN 0143-5221

Pugh, CJA, Sprung, VS, Kemp, GJ, Richardson, P, Shojaee-Moradie, F, Umpleby, AM, Green, DJ, Cable, NT, Jones, H and Cuthbertson, DJ (2014) Exercise training reverses endothelial dysfunction in nonalcoholic fatty liver disease. AMERICAN JOURNAL OF PHYSIOLOGY: HEART AND CIRCULATORY PHYSIOLOGY, 307 (9). H1298-H1306. ISSN 0363-6135

Cuthbertson, DJ, Weickert, MO, Lythgoe, D, Sprung, VS, Dobson, R, Shoajee-Moradie, F, Umpleby, M, Pfeiffer, AFH, Thomas, EL, Bell, JD, Jones, H and Kemp, GJ (2014) External validation of the fatty liver index and lipid accumulation product indices, using H-1-magnetic resonance spectroscopy, to identify hepatic steatosis in healthy controls and obese, insulin-resistant individuals. EUROPEAN JOURNAL OF ENDOCRINOLOGY, 171 (5). pp. 561-569. ISSN 0804-4643